2,4-dichlorobenzyl alcohol + amylmetacresol + ascorbic acid: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
2,4-dichlorobenzyl alcohol + amylmetacresol + ascorbic acid: clinical details
Prescribing considerations
- Confirm symptoms are suitable for self-care and assess persistent, recurrent, severe or rapidly worsening presentations.
- Consider the glucose and sucrose content in diabetes.
- Check excipients in people with wheat allergy, sulphite sensitivity or previous reactions to fragrances or azo colourings.
Contraindications and cautions
- Hypersensitivity to an active substance or excipient.
- Age under 6 years.
- Wheat allergy.
- Rare hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.
Monitoring
- Routine laboratory monitoring is not specified.
- Review symptom progression and investigate red flags or lack of improvement.
- Monitor for oral irritation, hypersensitivity and bronchospasm.
Clinical pharmacology
2,4-Dichlorobenzyl alcohol and amylmetacresol have local antiseptic properties. Ascorbic acid provides vitamin C. Product-specific pharmacokinetic information is not stated.
Formulation and product differences
- Orange-flavoured circular lozenge containing glucose and sucrose.
- Contains low-level gluten derived from wheat starch and is regarded as gluten-free for coeliac disease, but is unsuitable for wheat allergy.
- Contains sulphur dioxide, propylene glycol, fragrance allergens and the azo colourings sunset yellow and Ponceau 4R.
- Essentially sodium-free according to the product definition.
2,4-dichlorobenzyl alcohol + amylmetacresol + ascorbic acid interactions
No clinically significant medicine interactions are known for this product.
Other products for the same symptoms
Ask a pharmacist to check for unnecessary duplication.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.